A Hemoglobin Bionics‐Based System for Combating Antibiotic Resistance in Chronic Diabetic Wounds via Iron Homeostasis Regulation
Advanced Materials · 2024-07 · 36 (30)
DOI: 10.1002/adma.202405002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 19.05.2024. Verfasst von Yihan Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Joint Laboratory of Opto, Functional Theranostics in Medicine and Chemistry, The First Hospital of Jilin University, Changchun, 130021, P. R. China. Hauptthemen laut MEDLINE: Iron, Homeostasis, Gallium, Staphylococcus aureus. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Interdisciplinary Integration and Innovation Project of JLU, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Owing to the increased tissue iron accumulation in patients with diabetes, microorganisms may activate high expression of iron‐involved metabolic pathways, leading to the exacerbation of bacterial infections and disruption of systemic glucose metabolism. Therefore, an on‐demand transdermal dosing approach that utilizes iron homeostasis regulation to combat antimicrobial resistance is a promising strategy to address the challenges associated with low administration bioavailability and high antibiotic resistance in treating infected diabetic wounds. Here, it is aimed to propose an effective therapy based on hemoglobin bionics to induce disturbances in bacterial iron homeostasis. The preferred “iron cargo” is synthesized by protoporphyrin IX chelated with dopamine and gallium (PDGa), and is delivered via a glucose/pH‐responsive microneedle bandage (PDGa@GMB). The PDGa@GMB downregulates the expression levels of the iron uptake regulator (Fur) and the peroxide response regulator (perR) in Staphylococcus aureus , leading to iron nutrient starvation and oxidative stress, ultimately suppressing iron‐dependent bacterial activities. Consequently, PDGa@GMB demonstrates insusceptibility to genetic resistance while maintaining sustainable antimicrobial effects (>90%) against resistant strains of both S. aureus and E. coli , and accelerates tissue recovery (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Laboratory of Opto, Functional Theranostics in Medicine and Chemistry, The First Hospital of Jilin University, Changchun, 130021, P. R. China.
- State Key Laboratory of Supramolecular Structure and Material, Center for Supramolecular Chemical Biology, College of Chemistry, Jilin University, Changchun, 130012, P. R. China.
- Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Hospital of Stomatology, Jilin University, Changchun, 130021, P. R. China.
ORCID-Profile: Junhu Zhang
Förderung
- National Natural Science Foundation of China
- Interdisciplinary Integration and Innovation Project of JLU
- China Postdoctoral Science Foundation
- Bethune project of JLU
Zitieren
APA
Sun, Y., Liu, M., Sun, W., Tang, X., Zhou, Y., Zhang, J., & Yang, B. (2024). A Hemoglobin Bionics‐Based System for Combating Antibiotic Resistance in Chronic Diabetic Wounds via Iron Homeostasis Regulation. Advanced Materials, 36(30). https://doi.org/10.1002/adma.202405002
Vancouver
Sun Y, Liu M, Sun W, Tang X, Zhou Y, Zhang J, et al. A Hemoglobin Bionics‐Based System for Combating Antibiotic Resistance in Chronic Diabetic Wounds via Iron Homeostasis Regulation. Advanced Materials. 2024;36(30). doi:10.1002/adma.202405002
BibTeX
@article{Sun2024,
author = {Sun, Yihan and Liu, Manxuan and Sun, Weihong and Tang, Xiaoduo and Zhou, Yanmin and Zhang, Junhu and Yang, Bai},
title = {A Hemoglobin Bionics‐Based System for Combating Antibiotic Resistance in Chronic Diabetic Wounds via Iron Homeostasis Regulation},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {30},
doi = {10.1002/adma.202405002}
}
EUVIMED